The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...

FDA accepts Milestone's response on Cardamyst nasal spray, sets new PDUFA date; company raises $52.5 million to support ...

A mid-stage trial of BPL‑003 nasal spray shows promising results for treatment-resistant depression, igniting biotech ...

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...

New PDUFA Action Date of December 13, 2025 $75 Million Royalty Purchase Agreement Payment from RTW Extended Through 2025 MONTREAL and CHARLOTTE, N.C., July 11, 2025 (GLOBE NEWSWIRE) -- Milestone® ...

Milestone Pharmaceuticals (NASDAQ:MIST) announced on Friday that the U.S. FDA accepted for review its responses to the rejection letter sent early this year regarding its marketing application for its ...

The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for bumetanide nasal spray (RSQ-777) for the treatment of edema associated with congestive heart ...

Another will determine which human nasal tissues Zicam spray reaches. A third study will review health insurance data and anecdotal reports to determine the incidence of anosmia, Clarot said.

Colds, allergies and hay fever can cause nasal discomfort. An oxymetazoline nasal spray may offer the relief you need. Skip to content. FOX31 Denver.

Use the finest nasal spray bottles in 2024 to rid nasal congestion. Highest-Rated Nasal Spray Bottles of 2024 – Hollywood Life Reviews – Hollywood Life Skip to content ...